GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1326 - 1350** of **4050** in total

« First

‹ Prev

…

50

51

52

53

54

55

56

57

58

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgG	Patient 4	12	mild	G62826CL	91
IgM	Patient 2	24	mild	G00068MO	92
IgM	Patient 2	3	mild	G92823JK	92
IgM	Patient 3	-180	mild	G22768VO	92
IgM	Patient 3	-180	mild	G52880ZN	92
IgM	Patient 3	-180	mild	G92823JK	92
IgM	Patient 3	11	mild	G21460SG	92
IgG	Patient 4	12	mild	G40696TO	92
IgM	Patient 1	22	moderate	G14569AR	93
IgG	Patient 2	15	mild	G22768VO	93
IgM	Patient 2	3	mild	G84224TW	93
IgM	Patient 3	-180	mild	G21460SG	93
IgM	Patient 3	-180	mild	G47548GA	93
IgG	Patient 3	4	mild	G43534QA	93
IgG	Patient 4	12	mild	G02670IJ	93
IgG	Patient 4	12	mild	G82348BZ	93
IgM	Patient 2	15	mild	G32611KT	94
IgM	Patient 2	15	mild	G96865DJ	94
IgM	Patient 2	24	mild	G40696TO	94
IgG	Patient 2	3	mild	G47548GA	94
IgG	Patient 2	3	mild	G72424VO	94
IgM	Patient 3	-180	mild	G00052MO	94
IgM	Patient 3	-180	mild	G17390SF	94
IgM	Patient 3	-180	mild	G61751GZ	94
IgG	Patient 3	11	mild	G43534QA	94